SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-22-000058
Filing Date
2022-11-07
Accepted
2022-11-07 09:13:58
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sava-20220930x10q.htm   iXBRL 10-Q 2351605
2 EX-31.1 sava-20220930xex31_1.htm EX-31.1 25550
3 EX-31.2 sava-20220930xex31_2.htm EX-31.2 25249
4 EX-32.1 sava-20220930xex32_1.htm EX-32.1 20436
5 GRAPHIC sava-20220930x10qg001.jpg GRAPHIC 28862
6 GRAPHIC sava-20220930x10qg002.jpg GRAPHIC 30381
7 GRAPHIC sava-20220930x10qg003.jpg GRAPHIC 46460
8 GRAPHIC sava-20220930x10qg004.jpg GRAPHIC 31851
9 GRAPHIC sava-20220930x10qg005.jpg GRAPHIC 93477
  Complete submission text file 0001069530-22-000058.txt   7935293

Data Files

Seq Description Document Type Size
10 EX-101.SCH sava-20220930.xsd EX-101.SCH 33905
11 EX-101.CAL sava-20220930_cal.xml EX-101.CAL 43116
12 EX-101.DEF sava-20220930_def.xml EX-101.DEF 124641
13 EX-101.LAB sava-20220930_lab.xml EX-101.LAB 269028
14 EX-101.PRE sava-20220930_pre.xml EX-101.PRE 250841
60 EXTRACTED XBRL INSTANCE DOCUMENT sava-20220930x10q_htm.xml XML 1456751
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 221363995
SIC: 2834 Pharmaceutical Preparations